Davita Inc. (DVA) SEC Filing 8-K Material Event for the period ending Wednesday, February 9, 2022

Davita Inc.

CIK: 927066 Ticker: DVA

View differences made from one to another to evaluate Davita Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Davita Inc..


Assess how Davita Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Davita Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors



Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Material Contracts, Statements, Certifications & more

Davita Inc. provided additional information to their SEC Filing as exhibits

Ticker: DVA
CIK: 927066
Form Type: 8-K Corporate News
Accession Number: 0000927066-22-000002
Submitted to the SEC: Wed Feb 09 2022 5:03:52 PM EST
Accepted by the SEC: Wed Feb 09 2022
Period: Wednesday, February 9, 2022
Industry: Health And Allied
  1. Financial Exhibit
  2. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: